Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fosinopril: an overview

R Guthrie1

  • 1Department of Emergency Medicine, Ohio State University, Columbus.

The American Journal of Cardiology
|December 30, 1993
PubMed
Summary
This summary is machine-generated.

Angiotensin-converting enzyme (ACE) inhibitors effectively manage hypertension. Fosinopril, a newer ACE inhibitor, shows comparable efficacy and unique features warranting further investigation for hypertension treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone.

Diabetes, obesity & metabolism·2014
Same author

Development of flax/carbon fibre hybrid composites for enhanced properties.

Carbohydrate polymers·2013
Same author

Compensation: problems with the concept of disability and the use of American Medical Association Guides.

Journal of law and medicine·2002
Same author

Omapatrilat provides long-term control of hypertension: a randomized trial of treatment withdrawal.

Journal of clinical hypertension (Greenwich, Conn.)·2002
Same author

Community-acquired lower respiratory tract infections: etiology and treatment.

Chest·2001
Same author

Urinary leukotriene E(4) excretion during the first month of life and subsequent bronchopulmonary dysplasia in premature infants.

Chest·2001

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Internal Medicine

Background:

  • Angiotensin-converting enzyme (ACE) inhibitors are established treatments for mild-to-moderate hypertension.
  • Prescription rates for ACE inhibitors significantly increased from 1986 to 1990.
  • Emerging ACE inhibitors necessitate understanding pharmacokinetic and pharmacodynamic differences.

Purpose of the Study:

  • To review clinical data on fosinopril, a novel ACE inhibitor.
  • To explore the unique chemical structure and elimination profile of fosinopril.
  • To assess the clinical relevance of fosinopril's properties in hypertension management.

Main Methods:

  • Review of existing clinical data on fosinopril.
  • Comparative analysis of fosinopril's pharmacokinetics and pharmacodynamics with other ACE inhibitors.

Related Experiment Videos

  • Evaluation of preliminary data regarding cardiac effects and cough incidence.

    • Main Results:

    • Fosinopril exhibits a unique chemical structure and elimination pathway.
    • Preliminary findings suggest notable cardiac effects and a specific risk profile for cough.
    • Antihypertensive efficacy of fosinopril is comparable to existing ACE inhibitors.

    Conclusions:

    • Fosinopril demonstrates comparable antihypertensive efficacy to other ACE inhibitors.
    • Its unique characteristics, including cardiac effects and cough risk, merit further research.
    • Fosinopril is a valuable addition to the therapeutic options for hypertension.